regorafenib monohydrate
A monohydrate salt of Regorafenib, a multikinase inhibitor used in the treatment of metastatic colorectal cancer and advanced gastrointestinal stromal tumors. Shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition.Reference standards of Regorafenib Monohydrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.


Regorafenib Monohydrate
Catalogue No.:PA 18 35000
CAS :
1019206-88-2
Molecular Formula : C21H17ClF4N4O4
Molecular Weight : 500.83